Managing antithrombotic use during colonoscopy
Prospective Collection of Clinical and Laboratory Variables of Patients Receiving Antithrombotics and Requiring Colonoscopy
Chinese University of Hong Kong · NCT03363061
This study looks at how to safely manage blood-thinning medications for patients having a colonoscopy to see how it affects their risk of bleeding and blood clots.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 6000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Chinese University of Hong Kong (other) |
| Locations | 1 site (Hong Kong) |
| Trial ID | NCT03363061 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients who are on antithrombotics and are scheduled for elective colonoscopy. It aims to evaluate the management strategies for antithrombotic therapy in the context of invasive procedures, particularly the balance between the risks of thromboembolism and bleeding. The study will analyze the current practices and outcomes associated with antithrombotic use during colonoscopy, addressing the gaps in knowledge regarding bleeding risks. By utilizing data from patients undergoing this common procedure, the study seeks to provide insights into optimal management strategies.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old who are scheduled for elective colonoscopy and are currently receiving antithrombotic therapy.
Not a fit: Patients under 18 years of age or those unable to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved guidelines for managing antithrombotic therapy in patients undergoing colonoscopy, enhancing patient safety.
How similar studies have performed: While there is ongoing research in this area, the specific management of antithrombotics during colonoscopy remains underexplored, making this study a novel contribution.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients must be over 18 years of age * Patients undergoing elective colonoscopy for any indication, who are receiving antithrombotics * Informed consent is obtained Exclusion Criteria: * Patients under 18 years of age * Inability to give informed consent
Where this trial is running
Hong Kong
- Prince of Wales Hospital — Hong Kong, Hong Kong (RECRUITING)
Study contacts
- Principal investigator: Moe Htet Kyaw, MBBS — Chinese University of Hong Kong
- Study coordinator: Moe Htet Kyaw, MBBS
- Email: moehkyaw@cuhk.edu.hk
- Phone: 35053476
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Antithrombotics, Colonoscopy